Table 4 of Kubista, Mol Vis 2011; 17:2080-2092.
Final deletion count | Demographics | Diagnosis | |||||||
---|---|---|---|---|---|---|---|---|---|
CFH intron 1 | CFH exon 18 | CFHR3 | CFHR1 | CFHR4 | CFHR2 | Gender | Age | Affectation | Subtype |
1 | 0 | 0 | 0 | 0 | 0 | F | 77 | Control | |
1 | 0 | 0 | 0 | 0 | 0 | F | 66 | AMD | Early |
0 | 1 | 0 | 0 | 0 | 0 | M | 82 | AMD | Exudative |
0 | 1 | 0 | 0 | 0 | 0 | M | 72 | Control | |
0 | 1 | 1 | 0 | 0 | 0 | F | 69 | Control | |
0 | 0 | 1 | 0 | 0 | 0 | M | 65 | Control | |
0 | 0 | 1 | 0 | 0 | 0 | M | 85 | AMD | Exudative |
0 | 0 | 0 | 1 | 0 | 0 | F | 70 | Control | |
0 | 0 | 0 | 1 | 1 | 0 | F | 66 | AMD | Exudative |
0 | 0 | 0 | 1 | 1 | 0 | F | 43 | AMD | Early |
0 | 0 | 0 | 1 | 1 | 0 | F | 79 | AMD | Early |
0 | 0 | 0 | 1 | 1 | 0 | F | 89 | AMD | Exudative |
0 | 0 | 0 | 1 | 1 | 0 | M | 68 | AMD | Exudative |
0 | 0 | 0 | 1 | 1 | 0 | M | 88 | AMD | Exudative |
0 | 0 | 0 | 1 | 1 | 0 | F | 63 | Control | |
0 | 0 | 0 | 1 | 1 | 0 | F | 71 | AMD | Early |
0 | 0 | 0 | 1 | 1 | 0 | M | 66 | Control | |
0 | 0 | 0 | 1 | 1 | 0 | F | 86 | AMD | Exudative |
0 | 0 | 0 | 1 | 1 | 0 | F | 82 | Control | |
0 | 0 | 0 | 1 | 1 | 0 | F | 61 | Control | |
0 | 0 | 0 | 1 | 1 | 0 | F | 65 | Control | |
0 | 0 | 0 | 1 | 1 | 0 | F | 71 | Control | |
0 | 0 | 0 | 1 | 1 | 0 | M | 79 | Control | |
0 | 0 | 0 | 0 | 0 | 1 | M | 81 | AMD | Early |
0 | 0 | 0 | 0 | 0 | 1 | F | 90 | AMD | Exudative |
0 | 0 | 0 | 0 | 0 | 1 | M | 78 | AMD | Exudative |
0 | 0 | 0 | 0 | 0 | 1 | F | 84 | AMD | Early |
0 | 0 | 0 | 0 | 0 | 1 | F | 65 | AMD | Early |
0 | 0 | 0 | 0 | 0 | 1 | M | 68 | Control | |
0 | 0 | 0 | 0 | 0 | 1 | M | 71 | AMD | Exudative |